Combining Biophysical Screening and X-Ray Crystallography for Fragment-Based Drug Discovery
Author:
Publisher
Springer Berlin Heidelberg
Link
http://link.springer.com/content/pdf/10.1007/128_2011_225.pdf
Reference64 articles.
1. Ringe D (1995) What makes a binding site a binding site? Curr Opin Struct Biol 5:825–829
2. Boehm HJ, Boehringer M, Bur D, Gmuender H, Huber W, Klaus W, Kostrewa D, Kuehne H, Luebbers T, Meunier-Keller N, Mueller F (2000) Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening. J Med Chem 43:2664–2674
3. Erlanson DA, McDowell RS, O'Brien T (2004) Fragment-based drug discovery. J Med Chem 47:3463–3482
4. Rees DC, Congreve M, Murray CW, Carr R (2004) Fragment-based lead discovery. Nat Rev Drug Discov 3:660–672
5. Hubbard RE, Davis B, Chen I, Drysdale MJ (2007) The SeeDs approach: integrating fragments into drug discovery. Curr Top Med Chem 7:1568–1581
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Robust Strategy for Hit-to-Lead Discovery: NMR for SAR;Journal of Medicinal Chemistry;2023-09-21
2. Exiting the tunnel of uncertainty: crystal soak to validated hit;Acta Crystallographica Section D Structural Biology;2022-10-27
3. FAK inhibitors as promising anticancer targets: present and future directions;Future Medicinal Chemistry;2021-09
4. Applications of Solution NMR in Drug Discovery;Molecules;2021-01-22
5. A Structural View on Druggability;Structural Biology in Drug Discovery;2020-01-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3